A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04611802 |
Recruitment Status :
Completed
First Posted : November 2, 2020
Last Update Posted : December 21, 2023
|
Sponsor:
Novavax
Collaborator:
Department of Health and Human Services
Information provided by (Responsible Party):
Novavax
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 10, 2023 |
Actual Study Completion Date : | December 15, 2023 |
Certification/Extension First Submitted : | July 21, 2023 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):